IRD
IRD
NASDAQ · Biotechnology

Opus Genetics Inc

$3.01
+0.43 (+16.67%)
As of Feb 8, 2:05 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 29.54M 29.63M 31.10M
Net Income -1,183,263 -1,185,756 -1,130,465
EPS
Profit Margin -4.0% -4.0% -3.6%
Rev Growth +3.0% +20.7% -3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 68.97M 78.04M 72.81M
Total Equity 93.96M 103.70M 96.68M
D/E Ratio 0.73 0.75 0.75
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,626,848 -1,569,658 -1,729,159
Free Cash Flow -1,111,274 -1,455,645 -1,245,008